Search results
Marathon Capital Management Has $4.48 Million Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 days agoMarathon Capital Management grew its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.6% during the fourth quarter, according to the company in its most recent disclosure with ...
Johnson & Johnson (NYSE:JNJ) Stock Rating Reaffirmed by Royal Bank of Canada
ETF DAILY NEWS· 1 day agoJohnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank of Canada in a report issued on Wednesday, Benzinga reports.
Johnson & Johnson (NYSE:JNJ) Shares Bought by BI Asset Management Fondsmaeglerselskab A S
ETF DAILY NEWS· 4 days agoBI Asset Management Fondsmaeglerselskab A S lifted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 59.0% in the 4th quarter, according to the company in its most recent 13F filing ...
MainStreet Investment Advisors LLC Cuts Stock Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoMainStreet Investment Advisors LLC trimmed its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 2.7% during the 4th quarter, according to its most recent filing with the Securities ...
Johnson & Johnson (NYSE:JNJ) Position Reduced by Main Street Financial Solutions LLC
ETF DAILY NEWS· 4 days agoMain Street Financial Solutions LLC lowered its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.6% during the fourth quarter, according to its most recent Form 13F filing ...
Studies Show Linked Biological Pathways Driving Skin Inflammation
WFRV 5 Green Bay· 5 days agoA certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin disease psoriasis, a new study finds. The work could lead to improved therapies ...
Robeco Institutional Asset Management B.V. Sells 501,987 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoRobeco Institutional Asset Management B.V. reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 41.0% during the fourth quarter, according to its most recent 13F filing with the ...
AltruBio, after tweaking checkpoint drug, raises $225M for midphase ulcerative colitis program
FierceBiotech· 4 days agoAltruBio has roared back after another pivot in its twisty history, securing up to $225 million in series B funding to take an immune checkpoint enhancer through a midphase ulcerative colitis ...
Dynamic Technology Lab Private Ltd Reduces Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoDynamic Technology Lab Private Ltd decreased its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 59.3% during the 4th quarter, according to the company in its most recent ...
Prestige Wealth Management Group LLC Reduces Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoPrestige Wealth Management Group LLC lowered its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.6% during the fourth quarter, according to the company in its most recent filing with ...